Skip to main content

Table 1 Heterogeneous CAF subsets with anti-tumor functions

From: Cancer-associated fibroblasts and its derived exosomes: a new perspective for reshaping the tumor microenvironment

Cancer type

CAF subtype

Biological effect

Refs.

ER+ breast cancer

CD146pos CAFs

Maintain ER expression and sustain sensitivity to tamoxifen

Brechbuhl et al. (2017)

Pancreatic cancer

α-SMA+ CAFs

Mediate T-effector cell to Treg ratio and promote immune infiltration

McAndrews et al. (2022)

Breast Cancer

Asporin+ CAFs

Inhibition of TGF-β1-mediated SMAD2 phosphorylation, EMT process and stemness

Maris et al. (2015)

Fibrosarcoma

VCAN+ CAFs

Remodel the ECM and maintain the tumor-inhibitory functions

Fanhchaksai et al. (2016)

Lung cancer

low-HGF/low-FGF7 CAFs

Exert chemoattraction for immune cell infiltration and reverse ICB resistance

Hu et al. (2021a, b)

Pancreatic cancer

Meflin+ CAFs

Suppress the progression of tumor

Mizutani et al. (2019)

Pancreatic cancer

α-SMA+ CAFs

Inhibit accumulation of CD4 + FOXP3 + Tregs and immunosuppressive microenvironment formation

Ozdemir et al. (2014)